OSE Immunotherapeutics SA

10/11/2021 | Press release | Distributed by Public on 10/10/2021 23:31

OSE Immunotherapeutics Receives New European Patent Notice of Allowance for Tedopi® – Further Strengthens Global Intellectual Property Portfolio for Tedopi® until 2038